LAG3 and hepatocellular carcinoma: Initial studies demonstrated its ability to impede HCC progression [18], while recent findings have identified FGL1 as a functional ligand of lymphocyte activation gene 3 (LAG-3), thereby promoting HCC progression through modulation of the tumor microenvironment (TME) [19].